Quantcast

Latest Channelopathy Stories

2014-04-10 23:22:55

Novel Approach May Help to Prevent False Positive Cardiac Safety Findings in New Drug Development Philadelphia (PRWEB) April 10, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced it has entered into an agreement with GE Healthcare that enables ERT to introduce the QT Guard Plus Analysis System to the clinical trial industry as part of its centralized cardiac safety solutions. The QT Guard Plus Analysis...

2014-03-13 17:11:30

A rare and potentially lethal disease of newborn babies whose bodies make too much insulin may be treatable with fish oils, according to researchers from The University of Manchester. The disease, called congenital hyperinsulinism, means that the infant's brain is starved of blood sugar which can lead to brain damage or long-term disability. But by giving the children purified fish oils similar to those used to treat some heart attack patients, alongside standard medical treatment, their...

2014-03-12 08:29:44

BOULDER, Colo., March 12, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc. ("N30 Pharma") announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF). In preclinical studies, N91115 has been shown to rescue or "correct" F508del-CFTR, the most commonly occurring mutation in CF. It is the first oral GSNOR inhibitor to enter clinical...

2014-02-24 23:20:43

New research report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth” worked out by GBI Research is now available at MarketPublishers.com. According to the study, the combined value of the cystic fibrosis (CF) markets in the top 8 developed economies is set to grow at a 30.4% CAGR through 2019. London, UK (PRWEB) February 24, 2014 In 2012, the combined value of the cystic fibrosis (CF)...

Cystic Fibrosis Flare-ups May Be Caused By Buttery Molecule Diacetyl
2014-02-24 06:52:58

By Michael Price, San Diego State University Katrine Whiteson and colleagues identified a lung-damaging molecule in higher concentrations in cystic fibrosis patients during symptom flare-ups. A molecule previously linked to lung injuries in factory workers producing microwave popcorn might play an important role in microbial infections of the lung suffered by people with cystic fibrosis (CF), according to a recent study led by San Diego State University postdoctoral researcher Katrine...

2014-02-06 23:25:01

ResearchMoz.us include new market research report "Cystic Fibrosis Therapeutics in Major Developed Markets to 2019" to its huge collection of research reports. Full Report @ http://www.researchmoz.us/cystic-fibrosis-therapeutics-in-major-developed-markets-to-2019-cftr-modulators-initiate-drive-towards-personalized-treatment-and-market-growth-report.html Albany, NewYork (PRWEB) February 06, 2014 GBI Research has released its pharma report “Cystic Fibrosis Therapeutics in Major...

2014-01-14 23:21:24

Grant to Fulfill Wishes for Children Living with Cystic Fibrosis Narberth, PA (PRWEB) January 14, 2014 The Take a Breather Foundation is proud to announce that they have been awarded a $25,000 grant from the Julianna Hike Fund-Endowed of The Philadelphia Foundation. This grant will help the Take A Breather Foundation further it's mission of fulfilling wishes for children living with cystic fibrosis (CF). The Julianna Hike Fund focuses its support on organizations assisting children or...

2014-01-08 12:30:46

ATLANTA, Jan. 8, 2014 /PRNewswire/ -- The Celtaxsys Board of Directors today announced that Greg Duncan has been appointed as President and Chief Executive Officer (CEO) and will join the board of directors effective immediately. Mr. Duncan joins Celtaxsys following his most recent role as an Executive Committee member and President of North America for Brussels based UCB, prior to which he served as a Senior Vice-President at Pfizer where his duties included leading US marketing, as...

2013-12-10 23:27:46

19th Annual “The Eyes of Christmas™ ” Television Special for the Visually Impaired Kicks-off with “It’s A Wonderful Life,” Audio Described by former US President George H.W. Bush on Christmas Eve and is followed by Special Holiday Programming Hosted by Vin Scully and Hollywood Celebrities. Los Angeles (PRWEB) December 10, 2013 Helen Harris’ RP (Retinitis Pigmentosa) International --(http://www.rpinternational.org) the longest-standing non-profit organization leading the way...


Latest Channelopathy Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related